Contrast media: interactions with other drugs and clinical tests

被引:34
作者
Morcos, SK
Thomsen, HS
Exley, CM
机构
[1] Univ Copenhagen, Herlev Hosp, Dept Diagnost Radiol, DK-2730 Herlev, Denmark
[2] Sheffield Teaching Hosp NHS Trust, No Gen Hosp, Dept Diagnost Imaging, Sheffield S5 7AU, S Yorkshire, England
关键词
contrast media; interaction; biochemical measurements;
D O I
10.1007/s00330-004-2600-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Many patients with multiple medical problems who are receiving a variety of drugs are investigated with imaging techniques which require intravascular contrast media. The Contrast Media Safety Committee of the European Society of Urogenital Radiology therefore decided to review the literature and to draw up simple guidelines on interactions between contrast media and other drugs. An extensive literature search was carried out and summarized in a report. Based on the available information, simple guidelines have been drawn up. The report and guidelines were discussed at the 11th European Symposium on Urogenital Radiology in Santiago de Compostela. Contrast media may interact with other drugs, and may interfere with isotope studies and biochemical measurements. Awareness of the patient drug history is important to avoid potential hazards. Simple guidelines are presented.
引用
收藏
页码:1463 / 1468
页数:6
相关论文
共 32 条
[1]   METASTATIC RENAL-CELL CANCER - INTERLEUKIN-2 TOXICITY INDUCED BY CONTRAST AGENT INJECTION [J].
ABIAAD, AS ;
FIGLIN, RA ;
BELLDEGRUN, A ;
DEKERNION, JB .
JOURNAL OF IMMUNOTHERAPY, 1991, 10 (04) :292-295
[2]   Establishing safeguards for the use of imaging-related drugs [J].
Barrs, TJ .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (15) :1449-1453
[3]   DELAYED-REACTIONS TO CONTRAST-MEDIA AFTER INTERLEUKIN-2 IMMUNOTHERAPY [J].
CHOYKE, PL ;
MILLER, DL ;
LOTZE, MT ;
WHITEIS, JM ;
EBBITT, B ;
ROSENBERG, SA .
RADIOLOGY, 1992, 183 (01) :111-114
[4]   Pseudohypocalcemia with MR imaging contrast agents: A cautionary tale [J].
Choyke, PL ;
Knopp, MV .
RADIOLOGY, 2003, 227 (03) :627-628
[5]   ALTERATION OF BODY DISTRIBUTION OF TC-99M-PYROPHOSPHATE BY RADIOGRAPHIC CONTRAST MATERIAL [J].
CRAWFORD, JA ;
GUMERMAN, LW .
CLINICAL NUCLEAR MEDICINE, 1978, 3 (08) :305-307
[6]   IMPAIRMENT OF FIBRINOLYSIS BY STREPTOKINASE, UROKINASE AND RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN THE PRESENCE OF RADIOGRAPHIC CONTRAST AGENTS [J].
DEHMER, GJ ;
GRESALFI, N ;
DALY, D ;
OBERHARDT, B ;
TATE, DA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (05) :1069-1075
[7]   POSSIBLE FACTORS IN INTRAVASCULAR CONTRAST-MEDIA TOXICITY [J].
FISCHER, HW ;
MORRIS, TW .
INVESTIGATIVE RADIOLOGY, 1980, 15 (06) :S232-S238
[8]  
FROHLICH JM, 2001, SYSTEMATIC SURVEY IN
[9]   INTERACTION BETWEEN VERAPAMIL AND CONTRAST-MEDIA IN CORONARY ARTERIOGRAPHY - COMPARISON OF STANDARD IONIC AND NEW NON-IONIC MEDIA [J].
HIGGINS, CB ;
KUBER, M ;
SLUTSKY, RA .
CIRCULATION, 1983, 68 (03) :628-635
[10]  
JAKOBSEN JA, 2005, EUR RADIOL